GVP Module Safety Communication

First Page		Document Content
Date: 2013-07-21 06:39:02 Pharmaceutical sciences Pharmacovigilance European Medicines Agency Patient safety Summary of Product Characteristics Adverse effect Qualified Person Responsible For Pharmacovigilance EudraVigilance Medicine Health Pharmacology		GVP Module Safety Communication Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 179,10 KB Share Document on Facebook

	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 This medicinal product is subject to additional monitoring. This will allow quick identification of DocID: 1trcK - View Document
	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. DocID: 1tfLD - View Document
	BPGWorksharingEMA-CMDv DocID: 1rr9m - View Document
	B.08 GUIMA Transfer national requirements AT BE CZ DE(BVL, PEI) EE ES FI FR IE IS IT LT LV NL PL RO SE SK SI UKEMA-CMDv DocID: 1rcFm - View Document
	5th World Congress on Medicinal and Aromatic Plants WOCMAP 2014 Brisbane (Australia), 17-20 August 2014 New developments from the European Scientific Cooperative on Phytotherapy DocID: 1qSRs - View Document